Background and Objective: Photodynamic therapy (PDT) treats malignant tumors using photosensitizers and light. We employed a new pulse laser as the excitation light source for PDT, i.e. an optical parametric oscillator (OPO) system pumped by a Q-switched Nd:YAG laser, because it provides extremely high peak power.
INTRODUCTION
then emits a secondary laser beam of 630nm wavelength when the concentration of the dye is Photodynamic therapy (PDT) is a relatively adjusted to 0.4mM. The EDL has the following recently developed endoscopic method for treatcharacteristics: wavelength, 630nm; pulse energy, ing malignant tumors using a photosensitizer, 4mJ; peak power, 400kW; pulse width, 10ns; initially hematoporphyrin derivative (HpD), and frequency of repetition: 20, 30 or 40 Hz [6] . It a laser as the excitation light source [1, 2] . The was demonstrated in animal tumors [7] , in cliniprinciple of this method is to kill malignant cells cal studies on gastric cancer [8] , and also theoretby photo-chemical reaction rather than heat.
ically [9] that a pulse laser with an extremely Because HpD has a higher affinity for malignant high peak power is superior to a continuous wave tissue than normal tissue, after intravenous injeclaser in terms of the depth of photodynamic tion it is taken up and retained longer by maligaction. However, the structure of the EDL is nant tissue [3] . Thus by using weak laser light to complex and physicians feel it is difficult to use, irradiate the tumor region, malignant tissue can because it needs exchange of helium gas in the be destroyed selectively [4] . Photofrin Injection (R) Age ( 
